Grossman William Insider Trading Activity

Average Profitability
93.38%
Insider Buys Quantity
3
Insider Buys Sum
$10,344.56
Insider Sells Quantity
5
Insider Sells Sum
$439,337.54

Insider Activity of Grossman William

According to the SEC Form 4 filings, Grossman William, being in a position of

  1. Interim Chief Medical Officer at enGene Holdings Inc.,
    оver the last 12 months, has bought 5102 shares for $10,051, and sold 0 shares,
    over all time since 2026-09-22, has bought 5102 shares for $10,051, and sold 0 shares.

Biography of Grossman William

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $10,0511100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-09-22PurchaseenGene Holdings Inc.
ENGN
Interim Chief Medical Officer
5,102
0.0079%
$1.97$10,051-17.8%
2021-06-17SaleArcus Biosciences, Inc.
RCUS
Chief Medical Officer
3,891
0.0056%
$23.68$92,139+35.68%
2021-06-16SaleArcus Biosciences, Inc.
RCUS
Chief Medical Officer
3,174
0.0046%
$24.16$76,670+34.38%
2021-04-23SaleArcus Biosciences, Inc.
RCUS
Chief Medical Officer
4,133
0.0052%
$31.37$129,652-8%
2021-03-16SaleArcus Biosciences, Inc.
RCUS
Chief Medical Officer
2,127
0.0032%
$35.03$74,509-6.52%
2020-12-16SaleArcus Biosciences, Inc.
RCUS
Chief Medical Officer
2,117
0.0034%
$31.35$66,368+6.79%
2020-07-31PurchaseArcus Biosciences, Inc.
RCUS
Chief Medical Officer
200
0.0003%
$19.72$3,945+42.17%
2019-10-14PurchaseArcus Biosciences, Inc.
RCUS
Chief Medical Officer
600
0.0014%
$8.00$4,800+119.6%
2019-10-10PurchaseArcus Biosciences, Inc.
RCUS
Chief Medical Officer
200
0.0005%
$8.00$1,600+118.38%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.